<p>Individuals with a low antibody titer baseline (0–1) are in blue; those with a higher baseline (2–4) are in red.</p
Numbers of subjects that tested positive at baseline to at least one test- at high cut-off, in sever...
<p>Distribution frequency of total biopsy sample size for 2007 (blue) and 2012 (red).</p
<p>Median responses are shown in median fluorescence intensity minus background (MFI-BG) for antibod...
a) prevalence of infection and disease prevalence change during an intervention within the community...
a) prevalence of infection and disease prevalence change during re-emergence within the community, p...
<p>(A and B) For infected blood donors (A) or Cardiomyopathy cohort (B), mean raw values of the sum ...
<p><b>A</b>: Posterior distribution of the percentage of subjects with a 4 fold rise or more in AT (...
Number of patients positive by RDT (in red) and nasopharyngeal PCR (in blue) and sensitivity of RDT ...
1<p>diagnosed by PCR; <sup>2</sup>diagnosed by microscopy.</p><p>The number of positives (n) of the ...
<p>Relationships between average allele coverage, probability of detection, and the number of matchi...
On the left is the proportion of individuals positive in each diagnostic state prior to MDA occurrin...
<p>PD, peritoneal dialysis; PCR, polymerase chain reaction. Patients were divided to quartiles of pl...
<p><b><i>Group A1: RT PCR CHIKV positive patients. Group A2: RT PCR CHIKV negative, IgM anti CHIKV p...
<p>Serologic titers are graphed for the 12,634 subjects without prior or current VL, measured by rK3...
(A) CDRH3 length distribution averaged over individuals within each cohort of B cell receptors. A co...
Numbers of subjects that tested positive at baseline to at least one test- at high cut-off, in sever...
<p>Distribution frequency of total biopsy sample size for 2007 (blue) and 2012 (red).</p
<p>Median responses are shown in median fluorescence intensity minus background (MFI-BG) for antibod...
a) prevalence of infection and disease prevalence change during an intervention within the community...
a) prevalence of infection and disease prevalence change during re-emergence within the community, p...
<p>(A and B) For infected blood donors (A) or Cardiomyopathy cohort (B), mean raw values of the sum ...
<p><b>A</b>: Posterior distribution of the percentage of subjects with a 4 fold rise or more in AT (...
Number of patients positive by RDT (in red) and nasopharyngeal PCR (in blue) and sensitivity of RDT ...
1<p>diagnosed by PCR; <sup>2</sup>diagnosed by microscopy.</p><p>The number of positives (n) of the ...
<p>Relationships between average allele coverage, probability of detection, and the number of matchi...
On the left is the proportion of individuals positive in each diagnostic state prior to MDA occurrin...
<p>PD, peritoneal dialysis; PCR, polymerase chain reaction. Patients were divided to quartiles of pl...
<p><b><i>Group A1: RT PCR CHIKV positive patients. Group A2: RT PCR CHIKV negative, IgM anti CHIKV p...
<p>Serologic titers are graphed for the 12,634 subjects without prior or current VL, measured by rK3...
(A) CDRH3 length distribution averaged over individuals within each cohort of B cell receptors. A co...
Numbers of subjects that tested positive at baseline to at least one test- at high cut-off, in sever...
<p>Distribution frequency of total biopsy sample size for 2007 (blue) and 2012 (red).</p
<p>Median responses are shown in median fluorescence intensity minus background (MFI-BG) for antibod...
DOI
Add to ORKG